Skip to main content
Contact Us
Subscriber Sign In
navigation
サイト内検索
What We Do
Commercial Intelligence
Products
Evaluate Pharma
Evaluate Omnium
Evaluate Medtech
Evaluate Epi
Japan Drug Forecasts
Europe Drug Forecasts
CDMO Intelligence
Real World Data
Pharma Consulting & Analytics
Pharma Consulting & Analytics
Data Feeds
Evaluate Vantage
News
Analysis
Policy & Pricing
Insights
Events
Medtech
Therapy Areas
Evaluate for Biotech
How We Can Help You
Pharma and Biotech
Financial Services
Management Consultancies
Service Providers
Customer Testimonials
Thought Leadership
Multimedia
Blog
About Us
Press Releases
Media Coverage
Executive Team
Vision & History
Contact Us
Sign Up for Evaluate Vantage
Talent
Subscriber Sign In
Search
Open configuration options
Search
Vantage
News
Snippets
Deals
Trial results
Patents and litigation
Corporate strategy
Analysis
Interviews
Spotlight
Vantage points
Vantage views
Insights
M&A
IPO
NME approvals
Quarterly shareprice performance
Venture financing
Vantage data points
Other data
Events
Company events
Conferences
Upcoming events
Medtech
Therapy Areas
Breadcrumb
Home
Vantage
Articles
Insights
Vantage Data Points
Share Price Movers August 2019
September 05, 2019
Share price movers – August 2019
Edwin Elmhirst
Vantage Data Points
Related Companies
Allakos
Corindus Vascular Robotics
Fulgent Genetics
GlycoMimetics
Mallinckrodt
Opthea
T2 Biosystems
Verseon
ViewRay
Download PDF
Share This Article
Latest Reports
July 27, 2023
H1 Round Up: The haves and the have-nots
July 21, 2023
ADA/EASL eBook
Related Articles
July 20, 2023
Spotlight – scratching the surface of the urticaria pipeline
May 16, 2023
A slow (and low) year for FDA approvals
December 15, 2022
Ash 2022 roundup
December 14, 2022
Ash 2022 movers – Glycomimetics shakes off its sickle cell past
October 03, 2022
US FDA approval tracker: September 2022
